Misplaced Pages

Piperlongumine: Difference between revisions

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editContent deleted Content addedVisualWikitext
Revision as of 09:02, 31 October 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,084 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'ChEMBL').← Previous edit Latest revision as of 08:48, 4 September 2024 edit undoLeophiee (talk | contribs)3 editsm Fixed a link in the Chembox.Tag: Visual edit 
(53 intermediate revisions by 36 users not shown)
Line 1: Line 1:
{{Chembox {{Chembox
| Verifiedfields = changed
| verifiedrevid = 443167274
| Watchedfields = changed
| ImageFile = Piperlongumine.svg
| verifiedrevid = 458266837
| ImageSize = 200px
| ImageFile = Piperlongumine.svg
| IUPACName = 1--5,6-dihydropyridin-2(1''H'')-one | PIN = 1--5,6-dihydropyridin-2(1''H'')-one
| OtherNames = Piplartine | OtherNames = Piplartine
| Section1 = {{Chembox Identifiers | Section1 = {{Chembox Identifiers
| CASNo = 20069-09-4
| CASNo_Ref = {{cascite|correct|??}} | CASNo = 20069-09-4
| CASNo_Ref = {{cascite|correct|CAS}}
| UNII_Ref = {{fdacite|correct|FDA}}
| ChEMBL = 465843
| UNII = SGD66V4SVJ
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 465843
| PubChem = 637858 | PubChem = 637858
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 553441 | ChemSpiderID = 553441
| SMILES = O=C2\C=C/CCN2C(=O)\C=C\c1cc(OC)c(OC)c(OC)c1 | SMILES = O=C2\C=C/CCN2C(=O)\C=C\c1cc(OC)c(OC)c(OC)c1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI=1S/C17H19NO5/c1-21-13-10-12(11-14(22-2)17(13)23-3)7-8-16(20)18-9-5-4-6-15(18)19/h4,6-8,10-11H,5,9H2,1-3H3/b8-7+ | StdInChI=1S/C17H19NO5/c1-21-13-10-12(11-14(22-2)17(13)23-3)7-8-16(20)18-9-5-4-6-15(18)19/h4,6-8,10-11H,5,9H2,1-3H3/b8-7+
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = VABYUUZNAVQNPG-BQYQJAHWSA-N | StdInChIKey = VABYUUZNAVQNPG-BQYQJAHWSA-N
}} }}
| Section2 = {{Chembox Properties | Section2 = {{Chembox Properties
| C=17|H=19|N=1|O=5 | C=17 | H=19 | N=1 | O=5
| Appearance = | Appearance =
| Density = | Density =
| MeltingPt = | MeltingPt =
| BoilingPt = | BoilingPt =
| Solubility = | Solubility =
| SolubleOther = ], ], ]<ref name="MSDS">{{Cite web |date=October 1, 2018 |title=Safety Data Sheet Piperlongumine |url=https://www.chemblink.com/MSDS/MSDSFiles/20069-09-4_Cayman.pdf |access-date=April 4, 2022 |website=chemblink.com}}</ref>
}} }}
| Section3 = {{Chembox Hazards | Section3 = {{Chembox Hazards
| MainHazards = | MainHazards =
| FlashPt = | FlashPt =
| Autoignition = | AutoignitionPt =
| ExternalSDS = <ref name="MSDS" />
| GHSPictograms = {{GHS07}}
| GHSSignalWord = Warning
| HPhrases = {{H-phrases|315|319|335}}
| PPhrases = {{P-phrases|261|264|280}}
}} }}
}} }}


'''Piperlongumine''' (also called '''piplartine''' or '''piperlongumin''') is an ] ] constituent<ref name="pubchem">{{cite web |title=Piperlongumine |url=https://pubchem.ncbi.nlm.nih.gov/compound/Piperlongumine |publisher=PubChem, US National Library of Medicine |access-date=5 December 2020 |date=29 November 2020}}</ref> of the fruit of the ] (''Piper longum''), a pepper plant found in ] and ].<ref name="piska">{{cite journal | last1=Piska | first1=Kamil | last2=Gunia-Krzyżak | first2=Agnieszka | last3=Koczurkiewicz | first3=Paulina | last4=Wójcik-Pszczoła | first4=Katarzyna | last5=Pękala | first5=Elżbieta | title=Piperlongumine (piplartine) as a lead compound for anticancer agents – Synthesis and properties of analogues: A mini-review | journal=European Journal of Medicinal Chemistry| volume=156 | year=2018 | issn=0223-5234 | doi=10.1016/j.ejmech.2018.06.057 | pages=13–20|pmid=30006159}}</ref> When ]ed, piperlongumine may cause skin, eye or ] irritation.<ref name=pubchem/>
'''Piperlongumine''' (PL) is a ] constituent of the fruit of the ] (''Piper longum''),<ref name=Raj2011/> a pepper plant found in southern India and southeast Asia.


==Traditional medicine and research==
Piperlongumine may have anti-cancer properties. It selectively targets and kills cancer cells but leaving normal cells unharmed.<ref name=Raj2011>{{cite journal | doi = 10.1038/nature10167 | title = Selective killing of cancer cells by a small molecule targeting the stress response to ROS | year = 2011 | last1 = Raj | first1 = Lakshmi | last2 = Ide | first2 = Takao | last3 = Gurkar | first3 = Aditi U. | last4 = Foley | first4 = Michael | last5 = Schenone | first5 = Monica | last6 = Li | first6 = Xiaoyu | last7 = Tolliday | first7 = Nicola J. | last8 = Golub | first8 = Todd R. | last9 = Carr | first9 = Steven A. | journal = Nature | volume = 475 | issue = 7355 | pages = 231–234 | pmid = 21753854}}</ref> "In mice injected with human bladder, breast, lung, or melanoma cancer cells, PL inhibited tumor growth but showed no toxicity in normal mice. In a tougher test of mice that developed breast cancer spontaneously, PL blocked both tumor growth and metastasis."<ref>{{cite web|url=http://www.sciencedaily.com/releases/2011/07/110713131421.htm |title=Novel Compound Selectively Kills Cancer Cells by Blocking Their Response to Oxidative Stress | publisher = ScienceDaily | date=July 2011 }}</ref>
Long peppers have been used in ] and ] as a treatment.<ref name=piska/><ref name="ncats">{{cite web |title=Piperlongumine |url=https://drugs.ncats.io/drug/SGD66V4SVJ |publisher=US National Center for Advancing Translational Sciences |access-date=5 December 2020 |date=2020}}</ref>


], a biotechnology spin-off of the Portuguese Institute for Molecular Biology, developed a piperlongumine hydrogel that is to be applied after the removal of ] tumours, with the goal of neutralizing remaining cancer cells. The hydrogel was effective in laboratory and animal studies and is scheduled for Phase I human clinical trials sometime in 2023.<ref>{{Cite web|title=Research & Technology {{!}} TargTex|url=https://targtex.com/research-technology/|access-date=2022-02-11|language=en-US}}</ref><ref>{{Cite web|last=Renascença|date=2022-02-11|title=Português cria hidrogel de pimenta para combater cancro do cérebro - Renascença|url=https://rr.sapo.pt/especial/pais/2022/02/11/portugues-cria-hidrogel-de-pimenta-para-combater-cancro-do-cerebro/272024/|access-date=2022-02-11|website=Rádio Renascença|language=pt-pt}}</ref>
==References==

== References ==
{{reflist}} {{reflist}}


]
==External links==
]
*
]


]

Latest revision as of 08:48, 4 September 2024

Piperlongumine
Names
Preferred IUPAC name 1--5,6-dihydropyridin-2(1H)-one
Other names Piplartine
Identifiers
CAS Number
3D model (JSmol)
ChEMBL
ChemSpider
ECHA InfoCard 100.243.690 Edit this at Wikidata
PubChem CID
UNII
CompTox Dashboard (EPA)
InChI
  • InChI=1S/C17H19NO5/c1-21-13-10-12(11-14(22-2)17(13)23-3)7-8-16(20)18-9-5-4-6-15(18)19/h4,6-8,10-11H,5,9H2,1-3H3/b8-7+Key: VABYUUZNAVQNPG-BQYQJAHWSA-N
SMILES
  • O=C2\C=C/CCN2C(=O)\C=C\c1cc(OC)c(OC)c(OC)c1
Properties
Chemical formula C17H19NO5
Molar mass 317.341 g·mol
Solubility DMSO, DMF, ethanol
Hazards
GHS labelling:
Pictograms GHS07: Exclamation mark
Signal word Warning
Hazard statements H315, H319, H335
Precautionary statements P261, P264, P280
Safety data sheet (SDS)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). ☒verify (what is  ?) Infobox references
Chemical compound

Piperlongumine (also called piplartine or piperlongumin) is an amide alkaloid constituent of the fruit of the long pepper (Piper longum), a pepper plant found in southern India and southeast Asia. When extracted, piperlongumine may cause skin, eye or respiratory tract irritation.

Traditional medicine and research

Long peppers have been used in Ayurveda and traditional Chinese medicine as a treatment.

Targtex, a biotechnology spin-off of the Portuguese Institute for Molecular Biology, developed a piperlongumine hydrogel that is to be applied after the removal of Glioblastoma tumours, with the goal of neutralizing remaining cancer cells. The hydrogel was effective in laboratory and animal studies and is scheduled for Phase I human clinical trials sometime in 2023.

References

  1. ^ "Safety Data Sheet Piperlongumine" (PDF). chemblink.com. October 1, 2018. Retrieved April 4, 2022.
  2. ^ "Piperlongumine". PubChem, US National Library of Medicine. 29 November 2020. Retrieved 5 December 2020.
  3. ^ Piska, Kamil; Gunia-Krzyżak, Agnieszka; Koczurkiewicz, Paulina; Wójcik-Pszczoła, Katarzyna; Pękala, Elżbieta (2018). "Piperlongumine (piplartine) as a lead compound for anticancer agents – Synthesis and properties of analogues: A mini-review". European Journal of Medicinal Chemistry. 156: 13–20. doi:10.1016/j.ejmech.2018.06.057. ISSN 0223-5234. PMID 30006159.
  4. "Piperlongumine". US National Center for Advancing Translational Sciences. 2020. Retrieved 5 December 2020.
  5. "Research & Technology | TargTex". Retrieved 2022-02-11.
  6. Renascença (2022-02-11). "Português cria hidrogel de pimenta para combater cancro do cérebro - Renascença". Rádio Renascença (in European Portuguese). Retrieved 2022-02-11.
Categories:
Piperlongumine: Difference between revisions Add topic